DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,755 filers reported holding DANAHER CORPORATION in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $8,494,000 | -19.1% | 37,738 | -20.1% | 2.69% | -22.1% |
| Q4 2020 | $10,494,000 | +3.8% | 47,243 | +0.7% | 3.45% | -6.2% |
| Q3 2020 | $10,106,000 | +20.9% | 46,932 | -0.8% | 3.68% | +10.7% |
| Q2 2020 | $8,362,000 | +29.9% | 47,290 | +1.7% | 3.33% | +7.1% |
| Q1 2020 | $6,436,000 | -13.3% | 46,503 | -3.9% | 3.11% | +3.6% |
| Q4 2019 | $7,425,000 | +6.4% | 48,375 | +0.1% | 3.00% | +2.4% |
| Q3 2019 | $6,979,000 | +2.1% | 48,323 | +1.1% | 2.93% | -1.6% |
| Q2 2019 | $6,833,000 | -0.1% | 47,807 | -7.7% | 2.98% | -4.7% |
| Q1 2019 | $6,839,000 | +27.9% | 51,800 | -0.1% | 3.12% | +7.6% |
| Q4 2018 | $5,347,000 | -4.0% | 51,848 | +1.2% | 2.90% | +7.0% |
| Q3 2018 | $5,568,000 | +10.3% | 51,244 | +0.2% | 2.71% | -1.2% |
| Q2 2018 | $5,046,000 | +1.3% | 51,131 | +0.5% | 2.75% | -3.0% |
| Q1 2018 | $4,982,000 | +7.8% | 50,885 | +2.2% | 2.83% | +12.8% |
| Q4 2017 | $4,621,000 | +9.1% | 49,785 | +0.8% | 2.51% | -2.5% |
| Q3 2017 | $4,237,000 | +2.1% | 49,390 | +0.5% | 2.57% | -0.6% |
| Q2 2017 | $4,148,000 | +0.8% | 49,150 | +2.1% | 2.59% | -2.1% |
| Q1 2017 | $4,117,000 | +13.2% | 48,141 | +3.1% | 2.64% | +3.0% |
| Q4 2016 | $3,636,000 | +4.3% | 46,715 | +5.0% | 2.57% | -1.0% |
| Q3 2016 | $3,487,000 | -18.1% | 44,477 | +5.5% | 2.59% | -17.1% |
| Q2 2016 | $4,259,000 | +9.0% | 42,164 | +2.3% | 3.13% | +8.1% |
| Q1 2016 | $3,909,000 | +1.7% | 41,205 | -0.4% | 2.89% | -10.5% |
| Q4 2015 | $3,842,000 | +10.5% | 41,370 | +1.3% | 3.23% | +4.6% |
| Q3 2015 | $3,478,000 | -0.0% | 40,820 | +0.4% | 3.09% | +4.4% |
| Q2 2015 | $3,479,000 | +3.6% | 40,653 | +3.1% | 2.96% | +4.4% |
| Q1 2015 | $3,359,000 | -0.3% | 39,421 | +0.3% | 2.84% | -5.0% |
| Q4 2014 | $3,368,000 | +14.1% | 39,297 | +1.1% | 2.99% | +2.9% |
| Q3 2014 | $2,953,000 | -3.2% | 38,872 | +0.3% | 2.90% | -2.8% |
| Q2 2014 | $3,051,000 | +6.0% | 38,750 | +1.0% | 2.99% | +4.4% |
| Q1 2014 | $2,879,000 | -1.1% | 38,380 | +1.8% | 2.86% | -0.8% |
| Q4 2013 | $2,912,000 | – | 37,716 | – | 2.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |